dobbio
Home about Contact highlighted article Blog Linkedin
HomeaboutContacthighlighted articleBlogLinkedin
dobbio
doc.ai and UCB biopharma team up to develop breakthrough AI models to advance care
Nicola SteyaertNovember 25, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

Predicting Environmental Allergies from Real World Data Through a Mobile Study Platform

Nicola SteyaertMarch 31, 2021
Next

Differential methylation as a mediator of COVID-19 susceptibility

DNA-methylationNicola SteyaertSeptember 28, 2020sars-cov2, covid19, ace2, bioinformatics, DNA-methylation, epigenetics

VOF dobbio
BTW 0732.608.831
RPR Gent, afdeling Kortijk

Kouterweg 72
8870 Izegem
dobbio.info@gmail.com